Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Ivermectin to Enter 1st Company-Sponsored COVID-19 Trial in Japan
July 2, 2021
-
BUSINESS 3 Major Wholesalers, 7 Employees Found Guilty in Bid-Rigging Trial
July 2, 2021
-
BUSINESS Ayumi to Leverage IT to Boost Sales and Marketing, Eyes More Licensing Deals
July 2, 2021
-
BUSINESS New BMS Japan Boots Up with Richer Cancer Assets as Celgene Merger Closes
July 1, 2021
-
BUSINESS 2 Ono Employees Found Guilty for Onoact Bribery Charges; Scholarship Donation in Spotlight
June 30, 2021
-
BUSINESS Chugai Files Regeneron’s Antibody Cocktail in Japan
June 30, 2021
-
BUSINESS Organon Japan to Focus on Women’s Health, Enrich Offerings with Global Products: President
June 29, 2021
-
BUSINESS MSD Chief Wants Japan to Eliminate Disincentives Tied to Re-Pricing Rules as Keytruda Faces Repeated Cuts
June 28, 2021
-
ACADEMIA Architect of Oncolytic Virus Therapy Looks to Its Use in All Solid Cancers in 5 Years
June 25, 2021
-
BUSINESS Japan Pharma Market Forecast to Decline through FY2025: IQVIA
June 25, 2021
-
ACADEMIA Reproductive Medicine Society Issues Fertility Treatment Guidelines, Prods Careful Design for Health Coverage
June 25, 2021
-
REGULATORY Japan Approves Verquvo, Evrysdi, 2 CGRP Migraine Meds and More
June 24, 2021
-
REGULATORY Japan to Stop Accepting Requests for Moderna Vaccines for Workplace Inoculations
June 24, 2021
-
BUSINESS MSD Tops Foreign Pharma List in Japan in FY2020, but Big Players in a Melee
June 23, 2021
-
BUSINESS Otsuka Group Takes the Lead to Launch Workplace Vaccination as Industry Peers Set to Follow
June 22, 2021
-
BUSINESS Global Brands Clinch Targeted Sales despite COVID-19, Drive Japan Makers in FY2020
June 21, 2021
-
REGULATORY Japan OKs 2021 Fiscal Policy Blueprint, Vows Transparency in Drug Pricing
June 21, 2021
-
REGULATORY MHLW Aims to Set Up Evaluation Index, Sakigake System for SaMD by March
June 18, 2021
-
BUSINESS Merck’s COVID-19 Drug Candidate Enters PIII in Japan
June 18, 2021
-
BUSINESS Kyowa Adjusting Cymbalta Generic Supply before Launch as Rivals Delay Release
June 18, 2021
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…